Envoy Medical (COCHW) Common Equity (2020 - 2026)

Envoy Medical's Common Equity history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.

• In Q1 2026, Common Equity rose 141.95% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 141.95% YoY), while the FY2025 annual figure was -$12.2 million, up 35.47% from the prior year.
• Common Equity came in at $10.2 million for Q1 2026 at Envoy Medical, up from -$12.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $10.2 million in Q1 2026 to a low of -$47.5 million in Q1 2023.
• A 5-year average of -$19.1 million and a median of -$18.8 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 960.92% in 2024 and soared 141.95% in 2026, its largest moves.
• Envoy Medical's Common Equity stood at -$36.2 million in 2022, then surged by 95.09% to -$1.8 million in 2023, then tumbled by 960.92% to -$18.8 million in 2024, then soared by 35.47% to -$12.2 million in 2025, then soared by 183.57% to $10.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $10.2 million, -$12.2 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison